{"filings":[{"id":99970,"accession_number":"0001493152-26-021520","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"LifeMD Q1 revenue $50.2M beats guidance; adds 42k subscribers, record GLP-1 signups","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $50.2M vs guidance $48-49M; adj. EBITDA loss $4.5M in line.","Gross margin 88% (up ~420 bps YoY) on favorable mix & lower fulfillment costs.","Record GLP-1 new-patient revenues up ~120% QoQ; Women's Health signups up 657% QoQ with 70% lower CAC.","Subscribers exceeded 365k, net adds of 42k in Q1 (largest quarterly net addition).","Affirmed FY2026 revenue guidance $220-230M, adj. EBITDA $12-17M; cash $34.5M, no debt."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":50162956.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116283,"accession_number":"0001493152-26-011228","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"LifeMD appoints new CFO, promotes CBO and CMO; outgoing CFO to advise","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Marc Benathen resigns effective March 31, 2026; will provide advisory services for 6–12 months at $38,117/month.","Atul Kavthekar appointed CFO effective March 16, 2026; base salary $500,000, target bonus 50%, 675,000 RSU grant.","Jessica Friedeman promoted to Chief Business Officer to lead enterprise and employer health offerings.","Chris Pisano appointed Chief Marketing Officer; 25+ years marketing experience, oversees brand and digital strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116282,"accession_number":"0001493152-26-009380","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2026-03-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"LifeMD FY2025 rev $194.1M (+25%), adj EBITDA $15.3M (+309%); guides to >$250M run-rate by Q4 2026","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 revenue $194.1M (+25% YoY); adjusted EBITDA $15.3M (+309% YoY).","Q4 2025 revenue $46.9M (+4% YoY); adjusted EBITDA $4.8M (+348% YoY).","Launched oral Wegovy post-year-end; >80% of new weight management patients using branded therapy; Q1 sign-ups at record levels.","Ended 2025 with $36.8M cash, no debt; guides to annualized revenue >$250M and adj EBITDA >$25M by Q4 2026.","Benefits infrastructure on track to cover ~220M Americans in Q2 2026; women's health seeing strong early growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116281,"accession_number":"0001493152-26-000525","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"LifeMD closes $50M revolving credit facility with Citizens Bank, N.A.","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Facility provides $30M committed plus $20M accordion; maturity January 2, 2029.","No amount drawn at closing; Company cites sufficient cash flow for organic growth.","Interest based on Term SOFR + 1.50%-2.25% or ABR + 0.50%-1.25%; commitment fee 0.225%-0.30%.","No upfront fee; credit supports corporate development and shareholder value initiatives.","Financial covenants: leverage ratio ≤2.50x, interest coverage ≥3.00x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132744,"accession_number":"0001493152-25-023853","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeMD Q3 revenue $60.2M (+13%), adj EBITDA $5.1M; paid off debt, sold WorkSimpli","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $60.2M (+13% YoY); adjusted EBITDA $5.1M (+20% YoY).","Telehealth revenue $47.3M (+18% YoY); telehealth adjusted EBITDA $2.9M (+30% YoY).","Paid off all outstanding debt in Q3; divested majority stake in WorkSimpli after quarter end.","Pennsylvania 503-A compounding pharmacy approved; licensed in 14 states, pursuing 50-state license.","RexMD added nearly 10,000 net new subscribers; strong early traction in behavioral, women's, men's health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":186975039.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132743,"accession_number":"0001493152-25-020913","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"LifeMD delays Q3 earnings, expects late 10-Q filing due to $4.6M revenue recognition corrections","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q3 2025 earnings rescheduled to Nov 17, 2025; expects to file Form 12b-25 for late 10-Q.","Rev rec errors for periods ended Dec 31, 2023, Dec 31, 2024, and Jun 30, 2025; cumulative $4.6M (1.4% of cumulative revenue).","Adjustments do not materially impact reported revenue vs. guidance; no effect on cash flow or cash position.","Company's auditors have not completed review; adjustments may change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132742,"accession_number":"0001493152-25-020713","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["1.01","2.01","7.01","9.01"],"status":"ready","headline":"LifeMD sells majority stake in WorkSimpli for $65M enterprise value; receives $22M cash at close","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sold 80% of WorkSimpli units to buyer group led by founder/CEO; enterprise value ~$65M.","LifeMD received ~$22M cash at close (91.6% of $24M base price) for its 73.3% pre-sale ownership.","Sellers eligible for up to $28M additional cash if WorkSimpli meets growth/operational targets over 3 years.","LifeMD expects to use NOL carryforwards to offset most capital gains from the sale.","Transaction positions LifeMD as pure-play virtual care and pharmacy; plans cardiometabolic expansion in H1 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149277,"accession_number":"0001493152-25-012214","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"LifeMD dismisses CBIZ CPAs, appoints PwC; cites material weaknesses in internal controls","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On Aug 15, 2025, LifeMD dismissed CBIZ CPAs (appointed Apr 24, 2025) as auditor; no disagreements.","Reportable events: material weaknesses in ITGCs (user access, change management, SOC reports) and business process controls (IPE, review).","On Aug 18, 2025, Audit Committee appointed PricewaterhouseCoopers LLP as independent auditor for FY2025.","No prior consultations with PwC on accounting principles or audit opinion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149276,"accession_number":"0001641172-25-022258","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeMD Q2 revenue up 23% to $62.2M, adjusted EBITDA up 223% to $7.1M; revises FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $62.2M (+23% YoY), telehealth revenue $48.6M (+30%); telehealth adjusted EBITDA $3.4M (+560%).","Adjusted EBITDA $7.1M (+223% YoY); generated >$8M operating cash flow.","Paid down $2.1M senior debt, ended quarter with $36.2M cash; fully repaid all senior debt post-quarter.","Launched nationwide behavioral health offering, acquired virtual women's health brand, upgraded LifeMD+ membership.","Revised FY2025 guidance downward due to temporary challenges at Rex MD, still expects strong YoY growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":127915941.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149275,"accession_number":"0001493152-25-011523","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"LifeMD appoints Shayna Webb Dray as COO; promotes two other executives","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment of Shayna Webb Dray as COO effective March 27, 2025; base salary $400K, 100,000 RSUs with time and performance vesting.","Jessica Friedeman promoted to Chief Marketing and Product Officer, expanding role to include product oversight.","Jacob Ellison promoted to Chief Analytics Officer, overseeing data strategy, AI, and FP&A.","Ms. Webb Dray previously SVP Operations; led launch and scaling of weight management program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168305,"accession_number":"0001641172-25-015270","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"LifeMD shareholders elect seven directors, ratify auditor at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected directors: Justin Schreiber, Dr. Joseph DiTrolio, Roberto Simon, John Strawn, Dr. Joan LaRovere, William Febbo, Dr. Calum MacRae.","All director candidates received 'for' votes ranging from 16.8M to 21.6M; broker non-votes ~9.7M.","Ratified CBIZ CPAs, P.C. as independent auditor for FY 2025 with 31.5M for, 38K against, 179K abstain.","Quorum achieved at annual meeting held June 13, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168304,"accession_number":"0001641172-25-008841","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeMD Q1 revenue up 49% to $65.7M; first GAAP profit; raises FY 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $65.7M (+49% YoY); telehealth revenue up 70% to $55.8M.","GAAP net income $0.6M ($0.01 diluted EPS), first-ever positive GAAP EPS.","Adj. EBITDA $8.7M (vs. $0.1M); telehealth adj. EBITDA $5.3M (vs. -$1.3M).","FY 2025 guidance raised: revenue $268-275M, adj. EBITDA $31-33M.","Partnered with LillyDirect/NovoCare for branded GLP-1 access (Zepbound, Wegovy)."],"consensus_eps_estimate":-0.0476,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":65697756.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168303,"accession_number":"0001641172-25-006539","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"LifeMD acquires Optimal Human Health MD assets for 100k shares; launches women's health vertical","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired key assets from Optimal Human Health MD for 100,000 shares of common stock (50k at close, 50k at 1yr) plus earn-out.","Earn-out: up to 200k additional shares if patient/revenue milestones met (2,500/$2.5M or 5,000/$4.5M).","Dr. Doug Lucas joins LifeMD as VP, Female Health & Clinical Operations under 3-year employment agreement.","At least 75% of Optimal's employees accepted employment offers from LifeMD.","Women's health offering expected Summer 2025; addresses $60-70B market by 2030 per BCG."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168302,"accession_number":"0001641172-25-006228","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"LifeMD replaces auditor Marcum with CBIZ; cites material weaknesses in internal controls","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned as independent auditor on April 24, 2025; CBIZ CPAs P.C. appointed same day.","Prior reports for FY2024 and FY2023 were unqualified with no disagreements on accounting principles.","Reportable events: material weaknesses in ITGCs (user access, change management, SOC report review) and business process controls (IPE and review procedures).","CBIZ had acquired Marcum's attest business on November 1, 2024, prompting the transition.","No consultations with CBIZ prior to engagement on accounting or auditing matters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185487,"accession_number":"0001493152-25-009690","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeMD Q4 revenue $64.3M (+43% YoY), adj EBITDA $9.0M; FY2025 rev guidance $265-275M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $64.3M (+43% YoY); telehealth revenue $49.9M (+60%); GAAP net loss narrowed to $0.9M from $4.5M.","Adjusted EBITDA $9.0M, up 78% from $5.0M; telehealth adj EBITDA surged 396% to $5.9M.","Telehealth active subscribers 275k (+27% YoY); WorkSimpli subscribers 164k (+3%, sequentially up 3k).","Full-year 2025 guidance: revenue $265-275M, adj EBITDA $30-32M; expects gross margin 88-90%.","Ended 2024 with $35M cash; introduced Q1 2025 guidance rev $61-63M, adj EBITDA $5-7M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202077,"accession_number":"0001493152-24-052604","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2024-12-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"LifeMD raises CEO Justin Schreiber's base salary to $500,000 effective Jan 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chairman and CEO Justin Schreiber's annual base salary increases from $300,000 to $500,000, effective January 1, 2025.","Salary increase implemented via Second Amendment to Employment Agreement dated December 24, 2024.","All other terms of the prior Employment Agreement, including target bonus and equity grants, remain unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202076,"accession_number":"0001493152-24-051819","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"LifeMD board member Robert Jindal to resign effective Dec 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Jindal voluntarily resigned from LifeMD's board, effective December 31, 2024.","Mr. Jindal's resignation is not due to any disagreement with the company's operations, policies, or practices.","No replacement director has been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202075,"accession_number":"0001493152-24-043097","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"LifeMD director Naveen Bhatia resigns from board effective Oct 25, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Naveen Bhatia voluntarily resigned from LifeMD's board of directors.","Resignation effective October 25, 2024; no disagreement with company operations.","Company thanked Bhatia for his service and contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238069,"accession_number":"0001493152-24-024278","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2024-06-18T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"LifeMD stockholders approve 3M share increase in 2020 equity plan; all director nominees elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approved Third Amended and Restated 2020 Equity Plan, increasing share reserve by 3,000,000 shares (13,225,022 for, 8,347,423 against).","Elected nine directors; Justin Schreiber received highest votes (22,186,275 for), Roberto Simon lowest (15,381,405 for).","Non-binding advisory vote on executive compensation passed: 19,936,967 for, 2,250,462 against.","Ratified Marcum LLP as auditor for FY2024: 29,321,622 for, 288,475 against.","All four proposals passed at June 14, 2024 annual meeting; quorum of 29,831,868 shares present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238068,"accession_number":"0001493152-24-017571","cik":948320,"company_name":"LifeMD, Inc.","ticker":"LFMD","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"LifeMD appoints Dr. Calum MacRae, Harvard cardiologist, to board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. MacRae appointed as independent director effective April 26, 2024.","He is Vice Chair for Scientific Innovation, Brigham and Women's Hospital, and Harvard professor.","Compensation: 50,000 restricted shares vesting in three annual tranches through 2027.","MacRae's expertise includes cardiology, virtual care, and chronic disease management.","Press release issued April 29, 2024; no other material changes reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":221016661.6462264,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}